Suppr超能文献

神经退行性疾病:秀丽隐杆线虫的启示。

Neurodegenerative disorders: insights from the nematode Caenorhabditis elegans.

机构信息

Department of Neuroscience, Brown University, 185 Meeting Street, Providence, RI 02912, USA.

出版信息

Neurobiol Dis. 2010 Oct;40(1):4-11. doi: 10.1016/j.nbd.2010.05.012. Epub 2010 May 19.

Abstract

Neurodegenerative diseases impose a burden on society, yet for the most part, the mechanisms underlying neuronal dysfunction and death in these disorders remain unclear despite the identification of relevant disease genes. Given the molecular conservation in neuronal signaling pathways across vertebrate and invertebrate species, many researchers have turned to the nematode Caenorhabditis elegans to identify the mechanisms underlying neurodegenerative disease pathology. C. elegans can be engineered to express human proteins associated with neurodegeneration; additionally, the function of C. elegans orthologs of human neurodegenerative disease genes can be dissected. Herein, we examine major C. elegans neurodegeneration models that recapitulate many aspects of human neurodegenerative disease and we survey the screens that have identified modifier genes. This review highlights how the C. elegans community has used this versatile organism to model several aspects of human neurodegeneration and how these studies have contributed to our understanding of human disease.

摘要

神经退行性疾病给社会带来了沉重负担,但尽管已经确定了相关的疾病基因,这些疾病中神经元功能障碍和死亡的机制在很大程度上仍不清楚。鉴于神经元信号通路在脊椎动物和无脊椎动物物种中的分子保守性,许多研究人员转向秀丽隐杆线虫来确定神经退行性疾病病理学的机制。可以设计线虫来表达与人神经退行性疾病相关的人类蛋白;此外,还可以剖析秀丽隐杆线虫与人神经退行性疾病基因的同源物的功能。本文中,我们研究了再现人类神经退行性疾病许多方面的主要秀丽隐杆线虫神经退行性变模型,并调查了已鉴定修饰基因的筛选。这篇综述强调了秀丽隐杆线虫社区如何利用这种多功能生物来模拟人类神经退行性变的几个方面,以及这些研究如何促进我们对人类疾病的理解。

相似文献

1
Neurodegenerative disorders: insights from the nematode Caenorhabditis elegans.
Neurobiol Dis. 2010 Oct;40(1):4-11. doi: 10.1016/j.nbd.2010.05.012. Epub 2010 May 19.
2
Modeling human diseases in Caenorhabditis elegans.
Biotechnol J. 2010 Dec;5(12):1261-76. doi: 10.1002/biot.201000183. Epub 2010 Nov 29.
4
The contribution of neurogenetics to understanding neurodegenerative diseases.
J Neurogenet. 2020 Sep-Dec;34(3-4):527-548. doi: 10.1080/01677063.2020.1803302. Epub 2020 Aug 8.
5
Modeling neurodegenerative diseases in Caenorhabditis elegans.
Exp Neurol. 2013 Dec;250:94-103. doi: 10.1016/j.expneurol.2013.09.024. Epub 2013 Oct 2.
6
as a Model System to Study Human Neurodegenerative Disorders.
Biomolecules. 2023 Mar 5;13(3):478. doi: 10.3390/biom13030478.
7
Towards Understanding Neurodegenerative Diseases: Insights from .
Int J Mol Sci. 2023 Dec 28;25(1):443. doi: 10.3390/ijms25010443.
10
Caenorhabditis elegans as a model system for human diseases.
Curr Opin Biotechnol. 2020 Jun;63:118-125. doi: 10.1016/j.copbio.2019.12.011. Epub 2020 Jan 14.

引用本文的文献

1
Suppressing APOE4-induced neural pathologies by targeting the VHL-HIF axis.
Proc Natl Acad Sci U S A. 2025 Feb 4;122(5):e2417515122. doi: 10.1073/pnas.2417515122. Epub 2025 Jan 28.
3
Nucleoporin foci are stress-sensitive condensates dispensable for C. elegans nuclear pore assembly.
EMBO J. 2023 Jul 3;42(13):e112987. doi: 10.15252/embj.2022112987. Epub 2023 May 31.
4
Hort as a medicinal and edible plant foods: Antioxidant, anti-aging and neuroprotective properties in .
Front Pharmacol. 2022 Oct 26;13:1049890. doi: 10.3389/fphar.2022.1049890. eCollection 2022.
5
Neuroprotective potential of Cannabis sativa-based oils in Caenorhabditis elegans.
Sci Rep. 2022 Sep 13;12(1):15376. doi: 10.1038/s41598-022-19598-3.
6
Modifier pathways in polyglutamine (PolyQ) diseases: from genetic screens to drug targets.
Cell Mol Life Sci. 2022 May 3;79(5):274. doi: 10.1007/s00018-022-04280-8.
7
8
Automated phenotyping and lifespan assessment of a model of Parkinson's disease.
Transl Med Aging. 2020;4:38-44. doi: 10.1016/j.tma.2020.04.001. Epub 2020 Apr 19.
9
Amyotrophic Lateral Sclerosis: Proteins, Proteostasis, Prions, and Promises.
Front Cell Neurosci. 2020 Nov 4;14:581907. doi: 10.3389/fncel.2020.581907. eCollection 2020.
10
Drug Screening and Drug Repositioning as Promising Therapeutic Approaches for Spinal Muscular Atrophy Treatment.
Front Pharmacol. 2020 Nov 12;11:592234. doi: 10.3389/fphar.2020.592234. eCollection 2020.

本文引用的文献

1
The structure of the nervous system of the nematode Caenorhabditis elegans.
Philos Trans R Soc Lond B Biol Sci. 1986 Nov 12;314(1165):1-340. doi: 10.1098/rstb.1986.0056.
3
Global microRNA expression profiling of Caenorhabditis elegans Parkinson's disease models.
J Mol Neurosci. 2010 May;41(1):210-8. doi: 10.1007/s12031-009-9325-1. Epub 2010 Jan 21.
6
The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies.
J Neurochem. 2009 Sep;110(6):1737-65. doi: 10.1111/j.1471-4159.2009.06302.x. Epub 2009 Jul 23.
7
Repression of alpha-synuclein expression and toxicity by microRNA-7.
Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):13052-7. doi: 10.1073/pnas.0906277106. Epub 2009 Jul 23.
8
LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans.
J Neurosci. 2009 Jul 22;29(29):9210-8. doi: 10.1523/JNEUROSCI.2281-09.2009.
9
The Caenorhabditis elegans A beta 1-42 model of Alzheimer disease predominantly expresses A beta 3-42.
J Biol Chem. 2009 Aug 21;284(34):22697-702. doi: 10.1074/jbc.C109.028514. Epub 2009 Jul 2.
10
Rrs1 is involved in endoplasmic reticulum stress response in Huntington disease.
J Biol Chem. 2009 Jul 3;284(27):18167-73. doi: 10.1074/jbc.M109.018325. Epub 2009 May 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验